Mark Novas

2.3k citations
24 papers · 1.5k · 1 hit paper · h-index 8

Impact in

Papers in

    • Multiple Sclerosis Research Studies 13
    • Systemic Sclerosis and Related Diseases 1
    • Polyomavirus and related diseases 4
    • Cytokine Signaling Pathways and Interactions 2

Mark Novas

22 papers receiving 1.5k citations

Mark Novas's Hit Papers

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis 2012 · 1.0k citations
1.0k0+4+9Years since publication2505007501000

Peers

Mark Novas
Comparison fields: 5 of 92
  • Pathology and Forensic Medicine 1.1k
  • Neurology 327
  • Rheumatology 313
  • Neurology 136
  • Oncology 424
Replace Kartik Raghupathi with:
Kartik Raghupathi United States
Małgorzata Leyk United States
Alexander Korn Germany
Paul Frohna United States
Roberto Bomprezzi United States
Judith F. Ashouri United States
Batia Kaplan Israel
Ekokobe Fonkem United States
Carlos R. Ferreira United States
Sara Rollinson United Kingdom
Mark Novas relative to Kartik Raghupathi United States Kartik Raghupathi's profile →
Citations per field
00.5×1.5×
Kartik Raghupathi · 1×
Citations per year

Countries citing papers authored by Mark Novas

Since Specialization
Citations

This map shows the geographic impact of Mark Novas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Novas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Novas more than expected).

Fields of papers citing papers by Mark Novas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Novas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Novas. The network helps show where Mark Novas may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Novas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Novas Line = papers co-authored together Mark Novas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Hit paper breakdown →
20121036
2 2016109
3 201386
4 201374
5 201567
6 201549
7 201348
8 20138
9 20157
10 20146
11 20126
12 20155
13 20154
14 20124
15 20133
16 20133
17
Clinical and neuroimaging outcomes with BG-12 treatment in CONFIRM (comparator and an oral fumarate in relapsing-remitting multiple sclerosis), a multicenter, randomized, placebo-controlled, phase-3 study
20122
18
Effect of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study
20122
19 20142
20
Efficacy and Safety of BG-12 (Dimethyl Fumarate) in Relapsing-Remitting Multiple Sclerosis in the Phase 3 CONFIRM Study
20131

About Mark Novas

Mark Novas is a scholar working on Pathology and Forensic Medicine, Oncology, Ecology, Evolution, Behavior and Systematics, Epidemiology and Rheumatology, having authored 24 papers that have together received 1.5k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (13 papers), Fungal Plant Pathogen Control (4 papers), Polyomavirus and related diseases (4 papers), Mycobacterium research and diagnosis (4 papers), Cytokine Signaling Pathways and Interactions (2 papers), Pregnancy and Medication Impact (2 papers), Urticaria and Related Conditions (1 paper) and Systemic Sclerosis and Related Diseases (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (1.1k citations), Neurology (327 citations), Rheumatology (313 citations), Neurology (136 citations) and Oncology (424 citations). Mark Novas has collaborated with scholars based in United States, Czechia and Germany. Frequent co-authors include Robert J. Fox, J. Theodore Phillips, Eva Havrdová, Katherine Dawson, Vissia Viglietta, Mariko Kita, Michael Hutchinson, David H. Miller, Marianne T. Sweetser and Minhua Yang. Their work appears in journals such as Neurology, International Journal of MS Care, Journal of the Neurological Sciences, Current Medical Research and Opinion and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact